(Q33393823)

26 July 2017

1 reference

title

Immunomodulatory drugs and their application to the management of canine immune-mediated disease (English)

1 reference

26 July 2017

N T Whitley

1

1 reference

ORCID Public Data File 2021

author name string

M J Day

series ordinal

2

1 reference

26 July 2017

publication date

1 February 2011

1 reference

Journal of Small Animal Practice

26 July 2017

published in

1 reference

26 July 2017

volume

52

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

70-85

1 reference

Use of mycophenolate mofetil as a rescue agent in the treatment of severe generalized myasthenia gravis in three dogs

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Canine cutaneous and systemic histiocytosis: reactive histiocytosis of dermal dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

P-glycoprotein expression in lamina propria lymphocytes of duodenal biopsy samples in dogs with chronic idiopathic enteropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Use of mycophenolate mofetil in autoimmune and renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Glucocorticoids in T cell development and function*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Inhaled corticosteroids for asthma: are they all the same?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Th17: the third member of the effector T cell trilogy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

A prospective, randomized, double-blinded, placebo-controlled study of human intravenous immunoglobulin for the acute management of presumptive primary immune-mediated thrombocytopenia in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Treatment of severe immune-mediated thrombocytopenia with human IV immunoglobulin in 5 dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Treatment of Evans' syndrome with human intravenous immunoglobulin and leflunomide in a diabetic dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Multicentric lymphoma in a dog after cyclosporine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Platelet distribution width and mean platelet volume in the interpretation of thrombocytopenia in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Rapid glucocorticoid effects on immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Multiple papillomavirus-associated epidermal hamartomas and squamous cell carcinomas in situ in a dog following chronic treatment with prednisone and cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Endocrine and immunologic effects of inhaled fluticasone propionate in healthy dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Clinical and pathological features of protein-losing glomerular disease in the dog: a review of 137 cases (1985-1992).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Mycophenolate mofetil: a decade of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Antigen specificity in canine autoimmune haemolytic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Clinical forms of acquired myasthenia gravis in dogs: 25 cases (1988-1995).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2008).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Underlying diseases and clinicopathologic variables of thrombocytopenic dogs with and without platelet-bound antibodies detected by use of a flow cytometric assay: 83 cases (2004-2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

The role of infections in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Serum IgE and IgG responses to food antigens in normal and atopic dogs, and dogs with gastrointestinal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Possible therapeutic vaccines for canine myasthenia gravis: implications for the human disease and associated fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Canine glomerulonephritis: new thoughts on proteinuria and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Comparative effects of malononitriloamide analogs of leflunomide on whole blood lymphocyte stimulation in humans, rhesus macaques, cats, dogs, and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989-1999).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Therapy of immune mediated thrombocytopenia. A retrospective study of 15 dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

A scoring index for disease activity in canine inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Autoimmune Myasthenia Gravis: Recommendations for Treatment and Immunologic Modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Association of canine hypothyroidism with a common major histocompatibility complex DLA class II allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Thiopurine methyltransferase activity in red blood cells of dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide--mechanisms independent of pyrimidine depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

How promiscuity promotes tolerance: the case of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Leflunomide analog, MNA-715, plus cyclosporine reduces renal allograft rejection in mismatched dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Peptide-based therapeutic vaccines for allergic and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Canine idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune-mediated hemolytic anemia in dogs: a randomized controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Evaluation of liposomal clodronate in experimental spontaneous autoimmune hemolytic anemia in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Approaching the asymptote: 20 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Hypercalcaemia in two dogs caused by excessive dietary supplementation of vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Immunosuppressive therapy in the treatment of immune-mediated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Diagnostic use of cytologic examination of bone marrow from dogs with thrombocytopenia: 58 cases (1994-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Serum acute phase protein concentrations in dogs with autoimmune hemolytic anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Glomerulopathy with IgA deposition in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Cyclosporin and ketoconazole interaction for treatment of perianal fistulas in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Regulatory T cells and mechanisms of immune system control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Immune-mediated hemolytic anemia: 70 cases (1988-1996).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Review of the pharmacokinetics, interactions and adverse reactions of cyclosporine in people, dogs and cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Comparison of platelet count recovery with use of vincristine and prednisone or prednisone alone for treatment for severe immune-mediated thrombocytopenia in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Canine red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Advances in the pathogenesis of canine leishmaniosis: epidemiologic and diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Clinical signs, histology, and CD3-positive cells before and after treatment of dogs with chronic enteropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Myasthenia gravis: lessons from the past 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Spontaneous remission in canine myasthenia gravis: implications for assessing human MG therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Myasthenia gravis and disorders of neuromuscular transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

21 January 2018

Th9 and allergic disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Long-term prospective evaluation of topically applied 0.1% tacrolimus ointment for treatment of perianal sinuses in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Lupus-type "anticoagulant" in a dog with hemolysis and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Modulation of the cellular immune system by intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Effect of a single plasma transfusion on thromboembolism in 13 dogs with primary immune-mediated hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Prothrombotic and inflammatory effects of intravenous administration of human immunoglobulin G in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Clinical effects of short-term oral budesonide on the hypothalamic-pituitary-adrenal axis in dogs with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

The effects of cyclosporine versus standard care in dogs with naturally occurring glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Anti-endothelial cell antibodies in dogs with immune-mediated hemolytic anemia and other diseases associated with high risk of thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Platelet size, platelet surface-associated IgG, and reticulated platelets in dogs with immune-mediated thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Recovery of a dog from aplastic anaemia after treatment with mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Genome-wide association mapping identifies multiple loci for a canine SLE-related disease complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Shortage of human intravenous immunoglobulin—reasons and possible solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

Association of a common dog leucocyte antigen class II haplotype with canine primary immune-mediated haemolytic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-5827.2011.01024.X

10.1111/J.1748-5827.2011.01024.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference